ORIC
ORIC Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
5.10 / 10Overall Score
NeturalInvestment Rating
5.10 / 10Overall Score
NeturalInvestment Rating
Is ORIC a Good Buy Right Now?
- Based on a composite score of 5.10/10, we rate ORIC as a Netural. Our analysis breaks down into 3.96/10 for Fundamentals, 6.31/10 for Technicals, and 5.07/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of ORIC?
Is ORIC undervalued or overvalued?
Is money flowing into or out of ORIC?
Is ORIC a Good Buy Right Now?
- Based on a composite score of 5.10/10, we rate ORIC as a Netural. Our analysis breaks down into 3.96/10 for Fundamentals, 6.31/10 for Technicals, and 5.07/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is ORIC undervalued or overvalued?
Technical Analysis of ORIC?
Is money flowing into or out of ORIC?
